These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9488325)

  • 41. Laboratory measures of hemostasis and fibrinolysis after intravenous administration of epsilon-aminocaproic acid in clinically normal horses and ponies.
    Heidmann P; Tornquist SJ; Qu A; Cebra CK
    Am J Vet Res; 2005 Feb; 66(2):313-8. PubMed ID: 15757133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular markers of hemostatic mechanisms--thrombin-antithrombin III complex].
    Fukutake K
    Rinsho Byori; 1989 Mar; 37(3):261-5. PubMed ID: 2664281
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thrombin antithrombin III complex (TAT)].
    Sakuragawa N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():48-50. PubMed ID: 8753177
    [No Abstract]   [Full Text] [Related]  

  • 44. Combination of a SAW-biosensor with MALDI mass spectrometric analysis.
    Treitz G; Gronewold TM; Quandt E; Zabe-Kühn M
    Biosens Bioelectron; 2008 May; 23(10):1496-502. PubMed ID: 18316185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thrombin-antithrombin III complex (TAT)].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():585-7. PubMed ID: 10543185
    [No Abstract]   [Full Text] [Related]  

  • 46. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ; Velan T; Aldea GS; Chandler WL
    Thromb Res; 2006; 117(6):689-703. PubMed ID: 15996721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Measurement of thrombin-antithrombin III complex in plasma].
    Kuroso K; Koike K; Ikematsu S; Fujimaki M
    Rinsho Byori; 1988 Dec; 36(12):1421-5. PubMed ID: 3074186
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thrombin/antithrombin III complex (TAT)--a new parameter for detection of thrombotic states].
    Pelzer H
    Rinsho Byori; 1989 Apr; Spec No 81():198-201. PubMed ID: 2666687
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma levels of endothelin-1 and thrombin-antithrombin III complex in patients undergoing open chest operations.
    Onizuka M; Miyauchi T; Mitsui K; Suzuki N; Ueno H; Goto K; Masaki T; Hori M
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):559-60. PubMed ID: 8445938
    [No Abstract]   [Full Text] [Related]  

  • 51. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
    Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
    Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
    van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
    Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinolysis and fibrinogenolysis in liver disease.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Am J Hematol; 1990 Aug; 34(4):241-5. PubMed ID: 2195867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The relationship between the severity of a neurological condition and the blood coagulation/fibrinolytic system in patients with spontaneous subarachnoid hemorrhage].
    Kusanagi H; Teramoto A; Shimura T
    No Shinkei Geka; 2002 Apr; 30(4):399-403. PubMed ID: 11968826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma glycoprotein V levels in the general population: normal distribution, associated parameters and implications for clinical studies.
    Aleil B; Meyer N; Wolff V; Kientz D; Wiesel ML; Gachet C; Cazenave JP; Lanza F
    Thromb Haemost; 2006 Oct; 96(4):505-11. PubMed ID: 17003930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombin-antithrombin III and prothrombin fragment 1.2 levels in early respiratory distress syndrome.
    Yurdakök M; Yigit S; Gürakan B; Dündar S; Kirazli S
    Am J Hematol; 1996 Mar; 51(3):247-8. PubMed ID: 8619412
    [No Abstract]   [Full Text] [Related]  

  • 58. The coagulofibrinolytic state of patients with primary varicose veins of the lower legs.
    Ikeda M; Kambayashi J; Iwamoto S; Shinoki N; Nakamura T; Shibuya T; Kawasaki T; Monden M
    Surg Today; 1996; 26(12):985-9. PubMed ID: 9017960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does D-dimer formation in patients undergoing cardiopulmonary bypass (CPB) reflect primary fibrinolysis?
    Whitten CW
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):537-8. PubMed ID: 9188011
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hemostatic indices in different forms of Trichophyton rubrum mycosis].
    Shetsiruli LT; Kopaliani MSh; Makatsariia AD
    Vestn Dermatol Venerol; 1982 Sep; (9):18-22. PubMed ID: 7180187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.